Get the Stockscreener App
12.64
1.02%
-0.13
Pre-market:
12.61
-0.03
-0.24%
Tandem Diabetes Care Inc stock is traded at $12.64, with a volume of 1.08M.
It is down -1.02% in the last 24 hours and up +5.95% over the past month.
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for individuals with diabetes. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on Tobi (a tubeless version of Mobi), and the Sigi tubeless patch pump. Nearly three-quarters of total revenue is derived from the US, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one-third is from disposable infusion sets that need to be changed over every 2 to 3 days.
See More
Previous Close:
$12.77
Open:
$12.85
24h Volume:
1.08M
Relative Volume:
0.51
Market Cap:
$854.08M
Revenue:
$796.00M
Net Income/Loss:
$-136.49M
P/E Ratio:
-6.0478
EPS:
-2.09
Net Cash Flow:
$-64.24M
1W Performance:
+3.78%
1M Performance:
+5.95%
6M Performance:
-38.70%
1Y Performance:
-72.18%
1-Day Range:
$12.55
$13.10
1-Week Range:
$12.21
$13.52
52-Week Range:
$9.98
$47.60
Tandem Diabetes Care Inc Stock (TNDM) Company Profile
Name
Tandem Diabetes Care Inc
Sector
Industry
Phone
858-366-6900
Address
12400 HIGH BLUFF DRIVE, San Diego, CA
Compare TNDM with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TNDM
Tandem Diabetes Care Inc
|
12.64 | 862.86M | 796.00M | -136.49M | -64.24M | -2.09 |
|
ABT
Abbott Laboratories
|
133.89 | 236.51B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
98.06 | 144.75B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
371.22 | 142.80B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
95.74 | 121.80B | 34.20B | 4.69B | 5.30B | 3.63 |
|
EW
Edwards Lifesciences Corp
|
74.66 | 43.78B | 5.69B | 1.41B | 577.90M | 6.95 |
Tandem Diabetes Care Inc Stock (TNDM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-08-25 | Initiated | Oppenheimer | Outperform |
| Aug-12-25 | Upgrade | Citigroup | Sell → Neutral |
| Aug-07-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jul-09-25 | Downgrade | Citigroup | Neutral → Sell |
| Jun-16-25 | Initiated | Truist | Hold |
| Apr-10-25 | Initiated | Mizuho | Neutral |
| Mar-05-25 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Mar-04-25 | Downgrade | Citigroup | Buy → Neutral |
| Mar-03-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Feb-28-25 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Dec-02-24 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Nov-06-24 | Initiated | Bernstein | Outperform |
| Oct-04-24 | Initiated | Goldman | Neutral |
| Oct-02-24 | Initiated | RBC Capital Mkts | Outperform |
| Aug-22-24 | Initiated | Morgan Stanley | Equal-Weight |
| Aug-08-24 | Initiated | Canaccord Genuity | Buy |
| May-30-24 | Initiated | Redburn Atlantic | Buy |
| May-22-24 | Upgrade | Citigroup | Neutral → Buy |
| Apr-29-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Apr-25-24 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Mar-26-24 | Upgrade | Stifel | Hold → Buy |
| Aug-04-23 | Downgrade | Citigroup | Buy → Neutral |
| May-05-23 | Downgrade | BofA Securities | Neutral → Underperform |
| Apr-24-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Mar-29-23 | Initiated | UBS | Neutral |
| Jan-26-23 | Initiated | Wolfe Research | Peer Perform |
| Nov-15-22 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Oct-18-22 | Initiated | Barclays | Overweight |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Aug-09-22 | Downgrade | Wells Fargo | Overweight → Underweight |
| Mar-02-22 | Resumed | BofA Securities | Neutral |
| Jan-19-22 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jul-21-21 | Resumed | Cowen | Outperform |
| May-25-21 | Initiated | Barclays | Underweight |
| Dec-15-20 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Aug-20-20 | Initiated | Wells Fargo | Overweight |
| Jul-31-20 | Upgrade | Guggenheim | Neutral → Buy |
| Jul-06-20 | Upgrade | Citigroup | Neutral → Buy |
| Jun-18-20 | Reiterated | Raymond James | Outperform |
| Apr-24-20 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Mar-23-20 | Downgrade | Guggenheim | Buy → Neutral |
| Mar-05-20 | Initiated | Citigroup | Neutral |
| Feb-06-20 | Initiated | Raymond James | Outperform |
| Feb-04-20 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Oct-18-19 | Initiated | Guggenheim | Buy |
| Oct-04-19 | Upgrade | UBS | Neutral → Buy |
| May-17-19 | Reiterated | BofA/Merrill | Neutral |
| May-13-19 | Initiated | SVB Leerink | Outperform |
| Mar-08-19 | Initiated | BMO Capital Markets | Outperform |
| Mar-05-19 | Reiterated | BofA/Merrill | Neutral |
| Feb-27-19 | Reiterated | Lake Street | Buy |
| Nov-21-18 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Sep-26-18 | Reiterated | Dougherty & Company | Buy |
| Sep-26-18 | Reiterated | Piper Jaffray | Overweight |
View All
Tandem Diabetes Care Inc Stock (TNDM) Latest News
Rosen Law Firm Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action InvestigationTNDM - The Malaysian Reserve
18% Of This Tandem Diabetes Care Insider's Holdings Were Sold - 富途牛牛
Diabetes Care Market is Set to Boom: Strategic Outlook and Market Dynamics with Key Players like | Medtronic, Abbott, Pumps It, Inc. - industrytoday.co.uk
Tandem Diabetes (TNDM): Buy, Sell, or Hold Post Q2 Earnings? - Yahoo Finance
TNDM Investors Have Opportunity to Join Tandem Diabetes Care, Inc. Fraud Investigation with the Schall Law Firm - Business Wire
Did You Suffer Losses in Tandem Diabetes Care, Inc. (TNDM)? Contact Levi & Korsinsky About Securities Fraud Claims - ACCESS Newswire
Levi & Korsinsky Launches Fraud Investigation on Behalf of Tandem Diabetes Care, Inc. (TNDM) Shareholders - ACCESS Newswire
Does Tandem Diabetes Care Inc have pricing powerMarket Risk Report & Stepwise Entry and Exit Trade Signals - خودرو بانک
Aug Sectors: Is Tandem Diabetes Care Inc. a strong candidate for buy and holdWeekly Stock Summary & Consistent Income Trade Ideas - خودرو بانک
Aug Summary: Is Tandem Diabetes Care Incs growth already priced inDollar Strength & Weekly Market Pulse Updates - خودرو بانک
Tandem Diabetes Care, Inc. Investigation Ongoing: Contact Levi & Korsinsky to Discuss Your RightsTNDM - ACCESS Newswire
Growth Report: What is Tandem Diabetes Care Inc.’s valuation compared to sectorJuly 2025 Chart Watch & Comprehensive Market Scan Reports - khodrobank.com
Aug Spikes: Is MacKenzie Realty Capital Inc backed by strong institutional buyingMarket Performance Recap & Long Hold Capital Preservation Plans - khodrobank.com
TNDM Investor News: If You Have Suffered Losses in Tandem - GlobeNewswire
Why Tandem Diabetes (TNDM) Stock Is Up Today - TradingView
United States Insulin Pump Market Expansion Driven by Diabetes - openPR.com
Aug Analyst Calls: Should value investors consider Tandem Diabetes Care IncWeekly Trend Recap & Daily Profit Maximizing Tips - خودرو بانک
Tandem Diabetes Care Announces Publication Showing Adults With Type 2 Diabetes Benefit from Automated Insulin Delivery Regardless of C-Peptide Levels - BioSpace
Sell Signal: Is Tandem Diabetes Care Inc. stock risky to hold nowEarnings Performance Report & Capital Efficient Trade Techniques - خودرو بانک
Market Wrap: Whats the beta of Tandem Diabetes Care Inc stockJuly 2025 Setups & Technical Pattern Alert System - خودرو بانک
Tandem Diabetes (TNDM) Study Highlights Benefits of Control-IQ+ - GuruFocus
Tandem study- adults with type 2 diabetes benefit from automated insulin delivery, regardless of C-peptide levels - MarketScreener
About Us - FinancialContent
Aug Patterns: Does Tandem Diabetes Care Inc. have strong fundamentalsPortfolio Value Report & Reliable Breakout Stock Forecasts - خودرو بانک
Acadian Asset Management LLC Takes Position in Tandem Diabetes Care, Inc. $TNDM - MarketBeat
Value Recap: Will Tandem Diabetes Care Inc stock benefit from M AEarnings Growth Summary & Risk Managed Trade Strategies - خودرو بانک
Earnings Recap: How is Tandem Diabetes Care Inc managing supply chain issues2025 Fundamental Recap & Safe Entry Point Identification - خودرو بانک
Diabetes warning issued over insulin pump error - MSN
Market Trends: Is Tandem Diabetes Care Incs growth already priced inJuly 2025 Pullbacks & Consistent Return Investment Signals - خودرو بانک
Fda Tandem Diabetes Care Issues Correction For Certain TSlim X2 Insulin Pumps - MarketScreener
Analysis Recap: Is Tandem Diabetes Care Inc part of any major indexBond Market & Consistent Profit Trading Strategies - خودرو بانک
Weekly Recap: Is Tandem Diabetes Care Inc forming bullish engulfing patternsJuly 2025 Institutional & Low Risk High Reward Trade Ideas - خودرو بانک
Top 3 Health Care Stocks That Are Preparing To Pump This Month - Sahm
Jim Cramer Calls Tandem Diabetes “Speculative Stock for Younger People” - Yahoo
TNDM Investor News: If You Have Suffered Losses in Tandem Diabetes Care, Inc. (NASDAQ: TNDM), You Are Encouraged to Contact The Rosen Law Firm About Your Rights | Dow Theory Letters - FinancialContent
Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Sees Significant Drop in Short Interest - MarketBeat
Jim Cramer: This Is The Right Time To Buy This Energy Stock - Sahm
Jacobs Levy Equity Management Inc. Cuts Stock Position in Tandem Diabetes Care, Inc. $TNDM - MarketBeat
Rosen Law Firm Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action Investigation – TNDM | FinancialContent - FinancialContent
Rosen Law Firm Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action Investigation – TNDM - The Joplin Globe
Edmond DE Rothschild Holding S.A. Makes New $4.84 Million Investment in Tandem Diabetes Care, Inc. $TNDM - MarketBeat
Rosen Law Firm Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action Investigation – TNDM | Dow Theory Letters - FinancialContent
What data driven models say about Tandem Diabetes Care Inc.’s future2025 Pullback Review & Free Growth Oriented Trading Recommendations - Newser
Insulin pump makers Tandem and Insulet post contrasting Q2 results - MSN
Levi & Korsinsky Announces an Investigation on Behalf of Tandem Diabetes Care, Inc. (TNDM) Shareholders Who May Have Been Affected by Fraud - ACCESS Newswire
Elliott Wave Theory Predicts Pullback in Tandem Diabetes Care Inc.2025 Market Outlook & Technical Confirmation Trade Alerts - beatles.ru
Sessa Capital IM L.P. Acquires Shares of 4,466,307 Tandem Diabetes Care, Inc. $TNDM - MarketBeat
Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Receives Consensus Rating of "Hold" from Analysts - MarketBeat
RSI Crosses Above 30 for Tandem Diabetes Care Inc. — Reversal in SightJuly 2025 Intraday Action & Risk Adjusted Buy and Sell Alerts - beatles.ru
TNDM's Analyst Ratings: Oppenheimer Lowers Price Target by 50% | - GuruFocus
Oppenheimer Adjusts Tandem Diabetes Care Price Target to $22 From $44, Maintains Outperform Rating - MarketScreener
Tandem Diabetes Care Inc Stock (TNDM) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.25%
0.12%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):